Showing results (161-170 of 941) with videos related to

Sort By:
Pageof 95
Neurology and Therapy|September 19, 2025
Predictors of Post-Alteplase Long-Term Unfavorable Outcome in Atrial Fibrillation Patients Presented with Embolic Stroke in the Middle East and North Africa Regions: A Multi-center, Longitudinal StudyMohamed G Zeinhom, Mohamed Fouad Elsayed Khalil, Ahmad Galal Elmesallami, et al.
Neurology and Therapy|September 19, 2025
Treatment Preferences of Neurologists in Generalized Myasthenia Gravis: A Conjoint Analysis StudyLuis Querol, Rocío Gómez-Ballesteros, Gerardo Gutiérrez-Gutiérrez, et al.
Neurology and Therapy|September 19, 2025
The Difficult Journey of a Child with Dravet Syndrome: Perspectives from a Parent and the NeuropaediatricianRomain Reboux, Silvia Napuri
Neurology and Therapy|May 19, 2025
Pharmacokinetics, Pharmacodynamics, and Safety of Nipocalimab in Healthy Chinese Volunteers: A Single-Dose, Phase I StudyHaiyan Li, Juanfang Liu, Xiaohong Wang, et al.
Neurology and Therapy|May 17, 2025
Role of Immune Reconstitution Therapy with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in Older PatientsRaed Alroughani, Jihad Inshasi, Samar Farouk, et al.
Neurology and Therapy|May 12, 2025
Evaluating Cognitive Outcomes in Multiple Sclerosis: Real-World Impact of Ozanimod on Processing Speed Using BICAMSAurora Zanghì, Paola Sofia Di Filippo, Carlo Avolio, et al.
Neurology and Therapy|May 27, 2025
Disrupting Migraine Dynamics: A Narrative Review of the Consequences of Modern Anti-CGRP Monoclonal Antibody TherapiesDawn C Buse, Jan Versijpt, Hans-Christoph Diener
Neurology and Therapy|May 28, 2025
Continuous Dopaminergic Stimulation-Based Levodopa Treatment in Patients with Early to Mid-Stage Parkinson's Disease: A Systematic Review and Meta-AnalysisRong Tang, Sunying Zhang, Rui Sun, et al.
Neurology and Therapy|July 20, 2025
Clinical Performance of the Elecsys CSF pTau181/Aβ42 Ratio for Concordance with Tau-PET in Two Independent CohortsRuben Smith, Leslie Shaw, Sebastian Palmqvist, et al.
Neurology and Therapy|June 3, 2025
Cost-Consequences of Cladribine Tablets for the Treatment of Highly Active Relapsing-Remitting Multiple Sclerosis in ItalyBarbara Polistena, Anna Maria Provenzano, Caterina Rizzi, et al.
Pageof 95